Business Context and Reporting Period
Company: Mangoceuticals, Inc. (MGRX)
Filing Type: Form 8-K (Current Report)
Date of Report: December 2, 2024
Reporting Period: Events occurring on December 2, 2024, and December 4, 2024.
Key Financial Metrics and Transactions
This filing reports specific transactional events rather than periodic financial performance metrics (e.g., revenue, net income, or cash flow statements are not included).
- Service Agreement Compensation: Issuance of 40,000 restricted common shares and a cash fee of $40,000 to Greentree Financial Group, Inc.
- Equity Financing Proceeds: Net proceeds of $159,950 from the sale of 75,000 shares of common stock under an existing Equity Purchase Agreement (ELOC).
- Share Price: $2.50 per share for the ELOC transaction.
Material Changes and Agreements
Service Agreement with Greentree Financial Group, Inc.
On December 2, 2024, the Company entered a new service agreement with Greentree to replace a prior agreement that expired on September 30, 2024. Greentree's CFO, Mr. Eugene M. Johnston, has served as Audit Manager for Greentree since 2015.
- Services: Assistance with compliance filings (Q1-Q3 2025 and FY 2024), US GAAP review, liaison with third-party providers, and preparation of 2024 tax returns.
- Term: Effective through October 15, 2025, terminable with 45 days' notice.
- Payment Terms: $20,000 cash due by December 31, 2024, and $20,000 due by March 31, 2025. Early termination triggers immediate payment of the full cash fee.
Unregistered Sales of Equity Securities (ELOC)
On December 4, 2024, the Company executed an advance under its $25,000,000 Equity Purchase Agreement with Platinum Point Capital.
- Shares Sold: 75,000 shares.
- Pricing Mechanism: 90% of the gross proceeds received by the purchaser during the three trading days following the advance notice.
- Net Proceeds: $159,950 (after fees, discounts, and expenses).
- Exemption: Issued under Section 4(a)(2) and/or Rule 506 of Regulation D.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard legal disclosures regarding the unregistered nature of the securities issued.
Contingencies: The Service Agreement includes customary indemnification obligations. The ELOC allows for future issuances up to the $25 million commitment limit, subject to trading volume restrictions.
Investor Verification Checklist
- Verify the impact of the $40,000 cash outflow and 40,000 share issuance on the Company's current liquidity and diluted share count.
- Confirm the status of the $25,000,000 ELOC commitment with Platinum Point Capital and the remaining available capacity.
- Review the Company's upcoming compliance filings (Q1-Q3 2025 and FY 2024) to assess the effectiveness of the new Greentree service agreement.
- Monitor the Company's cash burn rate given the immediate $20,000 payment due to Greentree by December 31, 2024.